Cryoport Inc., a global provider of products and services to the cell and gene therapy industry, and NIPPON EXPRESS, entered into a strategic partnership to provide temperature-controlled supply chain services for the life sciences industry on a global basis.

The two companies will design and implement comprehensive supply chain solutions to support each other’s business efforts. The relationship brings together Nippon’s global logistics with Cryoport’s processes and equipment, including its shipping packages, data solutions, biostorage and bioservices, and the ability to provide  cell and gene therapy support services from upstream biomaterial collection to final delivery for dosing. 

Jerrell Shelton, CEO of Cryoport, said, “This partnership builds on our growing presence globally and bolsters our ability to service customers by benefiting from Nippon Express’ industry-leading global network. As an organization, Cryoport is committed to enhancing its logistics solutions and adding new capabilities to support the life sciences. Today’s collaboration is the latest in a series of strategic partnerships to build greater value for our clients as we fulfill this mission.” 

In a statement Nippon Express said, “We are excited to partner with Cryoport Systems, a recognized leader in providing temperature-controlled supply chain solutions. Working together we can leverage each other’s complementary strengths to meet the rapidly growing demand in the life sciences and biopharmaceutical industries for a complete supply chain solution.”